Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +22.98%
#3 Audiera Audiera +21.36%
#4 Velvet Velvet +19.74%
#5 Biconomy Biconomy +17.74%
#6 Geodnet Geodnet +16.44%
#7 aPriori aPriori +13.80%
#8 Quack AI Quack AI +13.49%
#9 Cross Cross +13.44%
#10 Humanity Humanity +11.22%
Coin of the day
MowCat MowCat
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Tissue Repair Ltd Tissue Repair Ltd

Tissue Repair Ltd

TRP
Peringkat dalam Saham #35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Harga Saham
$0.05994921
Terakhir disinkronkan: 2026-08-13
Kapitalisasi Pasar
$3.62M
Perubahan (1 hari)
-1.16%
Perubahan (1 tahun)
-66.49%
Negara
AU
Perdagangan Tissue Repair Ltd (TRP)

Kategori

Healthcare
Laba untuk Tissue Repair Ltd (TRP)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Tissue Repair Ltd, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Tissue Repair Ltd dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE